Adults aged 50 years and older demonstrate strong, durable immune responses after receiving an additional dose of the recombinant zoster vaccine.
Clonal B-cell–mediated hypogammaglobulinemia is common (up to 85%) and can coexist with qualitative immune defects that blunt vaccine responses and protection against encapsulated bacteria. T-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results